# Carmot Therapeutics

**Canonical:** https://apis.io/providers/carmot-therapeutics/  
**Website:** https://forgeglobal.com/carmot-therapeutics_stock/  
**APIs profiled:** 0

Carmot Therapeutics, Inc. is a clinical‑stage biotechnology company focused on developing therapeutics for obesity and diabetes. In early 2024 the company was acquired by Roche, becoming part of the Roche Group. The company leverages a chemotype evolution platform to discover novel incretin receptor signaling targets, advancing a pipeline of potential treatments for metabolic disease.

## Kin Score — 3.3 / 100 (minimal)

Scored 2026-10-09 under rubric 0.23.0.

| Facet | Score |
|---|---|
| Discoverability | 44.6 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 4.7 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Security (1)

- **Carmot Therapeutics Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Biotechnology, Clinical-stage, Obesity, Diabetes

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/carmot-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.